Chau Diane L, Edelman Steven V, Chandran Manju
Department of Geriatric Medicine, VA Sierra Health Care Systems, University of Nevada School of Medicine, 1000 Locust Street, MS 018, Reno, NV 89502, USA.
Curr Diab Rep. 2003 Feb;3(1):37-42. doi: 10.1007/s11892-003-0051-8.
Osteoporosis is the most prevalent metabolic bone disease in the United States. Although the disease has historically been reported mostly in white women, it can affect individuals of both sexes and all ethnic groups. The presence of osteoporosis related to diabetes is not well acknowledged and the impact of osteoporosis in a diabetic patient is often not considered. Routine screening or initiation of preventive medications for osteoporosis in all patients with type 1 or type 2 diabetes is not recommended at the present time. However, in all patients with diabetes, besides optimal glycemic control, general recommendations regarding adequate dietary calcium intake, regular exercise, and avoidance of other potential risk factors such as smoking should be given. In patients who have positive risk factors for osteoporosis, or in those who present with fractures, evaluation of bone density should be done and respective preventive or therapeutic interventions should be applied.
骨质疏松症是美国最常见的代谢性骨病。尽管历史上该病大多报道见于白人女性,但它可影响男女及所有种族的个体。与糖尿病相关的骨质疏松症的存在尚未得到充分认识,糖尿病患者中骨质疏松症的影响也常常未被考虑。目前不建议对所有1型或2型糖尿病患者进行骨质疏松症的常规筛查或启动预防性药物治疗。然而,对于所有糖尿病患者,除了优化血糖控制外,还应给出关于充足膳食钙摄入、定期锻炼以及避免其他潜在风险因素(如吸烟)的一般建议。对于有骨质疏松症阳性风险因素的患者,或出现骨折的患者,应进行骨密度评估并采取相应的预防或治疗干预措施。